Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep118 | Clinical case reports - Pituitary/Adrenal | ECE2017

Case with metastatic lung cancer who developed adrenal insufficiency

Bulbul Buket Yilmaz , Celik Ece , Celik Mehmet , Ayturk Semra , Ustun Funda , Guldiken Sibel

Adrenal metastasis is common (35%) among the patients with lung cancer, while less than 3% of the patients develop bilateral adrenal metastasis. Adrenal metastases are generally small and clinically asymptomatic. Adrenal insufficiency is rare despite the presence of adrenal metastasis. Lam et al. reported this ratio as 0.7%. We aimed to present a case with lung cancer and bilateral adrenal metastasis who developed adrenal insufficiency.A 63-year old male...

ea0049ep201 | Neuroendocrinology | ECE2017

A rare case: non-islet cell tumor hypoglycemia with adrenal insufficiency

Asoglu Veysi , Celik Mehmet , Bulbul Buket Yilmaz , Ayturk Semra , Ustun Funda , Guldiken Sibel

Non-islet cell tumor hypoglycemia (NICTH) is a rare paraneoplastic syndrome and is the second most common cause of tumor-related hypoglycemia following insulinoma. Its prevalence is not known and is likely that many cases would go undiagnosed. In here, we describe a patient with PNET who presented with severe hypoglycemia.A 37-year-old male with known metastatic Pancreatic neuroendocrine tumors (PNET) presented with weight loss, sweating, and tremor, epi...

ea0049ep1397 | Thyroid (non-cancer) | ECE2017

Insulin resistance and BRAFV600E mutation in the patients with differentiated thyroid carcinoma

Celik Mehmet , Yilmaz Bulbul Buket , Ayturk Semra , Tastekin Ebru , Can Nuray , Sezer Atakan , Ustun Funda

Aim: The incidence of nodular thyroid disease is high among patients with insulin resistance. The aim of this study is to evaluate the relationship between BRAFV600E mutation and insulin resistance in the patients with papillary thyroid cancer.Materials and methods: We examined clinical and laboratory data of 103 patients who had been followed up by our department between the years 2010 and 2015. The diagnosis of insulin resistance (IR) was made when the...

ea0049ep271 | Calcium & Vitamin D metabolism | ECE2017

A rare case: intrathymic parathyroid adenoma

Asoglu Veysi , Celik Mehmet , Bulbul Buket Yilmaz , Ayturk Semra , Tastekin Ebru , Can Nuray , Sezer Atakan , Ustun Funda , Guldiken Sibel

Primary hyperparathyroidism in the most common cause of hypercalcemia. 87% of the cases present with single adenoma, 9% of them have hyperplasia, while multiple adenomas and parathyroid malignancy are detected in 3 and 1% of the cases, respectively. Although it is rare, parathyroid adenomas may be ectopic. The most common locations for ectopic parathyroid adenomas are thymus, tracheaesophageal cleft, carotis sheet, intrathyroidal and paraesophageal area. In this study, we aime...

ea0049ep848 | Clinical case reports - Pituitary/Adrenal | ECE2017

A rare case with acromegaly: increased hypophyseal FDG uptake in PET/CT performed for lung cancer staging

Asoglu Veysi , Celik Ece , Celik Mehmet , Bulbul Buket Yilmaz , Durmus Yusuf , Ayturk Semra , Ustun Funda , Guldiken Sibel

Acromegaly affects 4–6 people in a million and hypophyseal GH releasing adenoma is the most common cause of the disease. It shows its effects on GH and IGF1. Since they grow rapidly, they are usually diagnosed at the stage of macroadenomas. Heart failure, arthritis, OSAS and DM may develop during course of the disease. Although the most common accompanying malignancy is colon cancer, the incidence of malign melanoma, breast, thyroid, gastric and lung cancers is also incre...

ea0049ep981 | Pituitary - Clinical | ECE2017

Clinical and histopathologic characteristics of thyroid cancer in the patients with acromegaly

Bulbul Buket Yilmaz , Celik Mehmet , Can Nuray , Ayturk Semra , Tastekin Ebru , Sezer Atakan , Ustun Funda , Guldiken Sibel

Aim: There are some studies suggesting that the risk of developing cancers,especially thyroid cancer, is increased in the patients with acromegaly. The prevalence of thyroid cancer is 1.2-10.6% among the patients with acromegaly. In this study, we aimed to evaluate clinical and histopathologic characteristics of thyroid cancer among the patients with acromegaly.Method: We retrospectively evaluated the patients with acromegaly who had been followed-up by ...

ea0049ep1198 | Clinical case reports - Thyroid/Others | ECE2017

Hyalinizing trabecular tumor of the thyroid gland

Bulbul Buket Yilmaz , Celik Mehmet , Ayturk Semra , Can Nuray , Tastekin Ebru , Sezer Atakan , Ustun Funda , Guldiken Sibel

Hyalinizing trabecular tumor is an uncommon, controversial lesion of thyroid gland. Hyalinizing trabecular neoplasm share similarities with medullary thyroid carcinomas (MTC) and exhibit nuclear features resembling papillary thyroid carcinoma (PTC). However, the clinical behaviour unclear. We aimed to present a rare case of hyalinizing trabecular tumor of thyroid gland and ten-year follow up. A 54-year-old woman who was being followed up because of multinodular goiter on exami...

ea0049ep1396 | Thyroid (non-cancer) | ECE2017

The relationship between extrathyroidal extension and BRAFV600E mutation in papillary thyroid cancer

Celik Mehmet , Yilmaz Bulbul Buket , Ayturk Semra , Can Nuray , Tastekin Ebru , Sezer Atakan , Ustun Funda , Guldiken Sibel

Aim: BRAF is one of the serine threonin kinases that activates mitogen activated protein kinase (MAPK) signal pathway.The aim of this study is to evaluatethe relationship between extrathyroidal extension (ETE) and BRAFV600E mutation in the subjects with papillary thyroid cancer.Materials and methods: Clinical and laboratory data of 455 patients, who had been followed-up in our clinic between the years 2010 and 2015 for PTC, were evaluated. The relationsh...

ea0049ep1399 | Thyroid (non-cancer) | ECE2017

Complementary thyroidectomy in papillary thyroid cancer

Durmus Yusuf , Celik Mehmet , Bulbul Buket Yilmaz , Ayturk Semra , Tastekin Ebru , Can Nuray , Sezer Atakan , Ustun Funda , Guldiken Sibel

Aim: ATA guideline recommends complementary thyroidectomy after thyroid lobectomy in case of tumor diameter>1 cm, in the presence of metastatic tumor, invasion, history of radiation therapy, familial history of thyroid cancer, multifocal or agressive variant tumor. In this study, we aimed to evaluate the relationship between the necessity of complementary thyroidectomy and post-surgery clinical, radiologic and histopathologic results in the patients who underwent complemen...

ea0049ep1400 | Thyroid (non-cancer) | ECE2017

A case report: co-occurence of medullary thyroid carcinoma and papillary thyroid carcinoma

Camur Beliz , Celik Mehmet , Bulbul Buket Yilmaz , Ayturk Semra , Tastekin Ebru , Can Nuray , Sezer Atakan , Ustun Funda , Guldiken Sibel

Introduction: Co-occurence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same patient is unusual. We report a case with this rare event.Case: A 39 year old woman was presented with cough and shortness of breath. She had no prior history of radiation exposure, cigarette or alcohol consumption and no family history of thyroid cancer. On physical examination, a 3x5 cm thyroid nodule was palpated in the middle portion of thyroid gland...